Herbert Newton, MD
- Medical Director, Brain Tumor Center, UH Seidman Cancer Center
- Director, Neuro-Oncology, UH Cleveland Medical Center
- William Burton Risman Chair in Memory and Cognition, University Hospitals
- Specialty: Neurology-Neuro-Oncology
-
Location:UH Seidman Cancer Center
11100 Euclid Ave
Cleveland, OH 44106
- Call: 216-844-3951
Biography: Herbert Newton, MD
Expertise
Certifications & Memberships
- Neurology - American Board of Psychiatry and Neurology
- Neuro-Oncology – United Council of Neurological Specialies
Education
Fellowship | Neuro-oncology
Neuro-oncology - Memorial Sloan-Kettering Cancer Center (1988 - 1990)
Residency | Neurology
Neurology - University Of Michigan Medical Center/University Of Michigan Health System (1985 - 1988)
Internship | Internal Medicine
Internal Medicine - Erie County Medical Center (1984 - 1985)
Medical Education
University At Buffalo Suny Jacobs School Of Medicine And Biomedical Sciences (1984)
Professional Education
University At Buffalo (1980)
Undergraduate
University At Buffalo (1979)
About
Herbert Newton, MD, FAAN, is a neuro-oncologist and Medical Director of the Brain Tumor Center at University Hospitals Seidman Cancer Center. Dr. Newton graduated from SUNY Buffalo with high honors in psychology, before pursuing a master’s degree in cancer chemotherapy and pharmacology from the Roswell Park Cancer Institute. He then entered the SUNY Buffalo School of Medicine, graduating in 1984. After an internship in internal medicine with the SUNY Buffalo Health System, he was trained in neurology at the University of Michigan Medical Center in Ann Arbor, MI, followed by a fellowship in neuro-oncology at the Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City.
After the completion of his fellowship at MSKCC, Dr. Newton joined the faculty in Neurology at The Ohio State University Medical Center (OSUMC) and James Cancer Hospital, establishing a Division of Neuro-Oncology within the Department of Neurology. Dr. Newton achieved the rank of Full Professor of Neurology with tenure and was appointed the Esther Dardinger Endowed Chair in Neuro-Oncology in 2003.
His interests include clinical neuro-oncology, chemotherapy, molecular biology, molecular therapeutics, and clinical trials. After retiring from OSUMC in 2015, he then became the Director of the Neuro-Oncology Center for the Advent Health Cancer Institute and Advent Health Orlando campus, before returning to Ohio and UH in 2023. He has published more than 220 scientific articles and book chapters, and is the editor or co-editor of 12 books in the fields of neurology and neuro-oncology.
Research & Publications
Research Interests
Neuro-Oncology overall, but focusing on brain tumors; mainly high-grade gliomas and GBM, oligodendrogliomas, meningiomas, etc; chemotherapy, molecular therapeutics, clinical trials, NF-1 and NF-2, brain tumor-related epilepsy, brain metastases, leptomeningeal disease.
Featured Videos
Watch to find out more about this University Hospitals provider.